US 11844841
Dosing regimens and related compositions and methods
granted A61KA61K38/00A61K47/60
Quick answer
US patent 11844841 (Dosing regimens and related compositions and methods) held by Apellis Pharmaceuticals, Inc. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/643, A61K47/6901